EUVIMEDEUVIMED entdecken
Fallbericht

Distinct B/myeloid and T-lymphoblast populations at separate anatomic sites in mixed-phenotype acute leukemia with BCR::ABL1 fusion

Gina L Sotolongo, Luis F Carrillo, Ken H Young, Jadee L Neff, Eric D Carlsen

Journal of Hematopathology · 2025

DOI: 10.1007/s12308-025-00660-8 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Hematopathology, 2025. Verfasst von Gina L Sotolongo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Duke University School of Medicine, Durham, NC, USA. Hauptthemen laut MEDLINE: Fusion Proteins, bcr-abl, Leukemia, Biphenotypic, Acute. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The pluripotency of malignant blasts in acute leukemias is a growing area of scientific and clinical interest. Mixed-phenotype acute leukemias (MPALs) are defined by the presence of blasts showing evidence of differentiation along at least two lineages. Curiously, MPALs exhibit some of the same recurrent cytogenetic abnormalities (e.g., BCR::ABL1, KMT2A rearrangements) that are seen in single-lineage acute leukemias. Factors that contribute to phenotypic selection and divergence of blast populations in single-lineage and mixed-phenotype acute leukemias are incompletely understood. Optimal therapeutic management of MPAL also remains a matter of debate. Herein, we present a case of MPAL with BCR::ABL1 fusion that showed distinct T-lymphoblastic and B-lymphoblastic/myeloblastic populations at different anatomic sites (tonsil and bone marrow, respectively). Both blast populations showed clonally related TRG rearrangements with evidence of clonal evolution. The patient initially responded to tyrosine kinase inhibitor therapy, but he quickly relapsed and expired a year after diagnosis. To our knowledge, this is the first time an MPAL has been shown to have different blast lineages segregated to distinct anatomic sites in a treatment-naïve patient. This case emphasizes the importance of a multifaceted diagnostic approach to acute leukemias and highlights what is left to learn about the biology and management of these poorly understood neoplasms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fusion Proteins, bcr-ablLeukemia, Biphenotypic, AcuteHumansMaleMiddle Aged

Stichwörter der Autor:innen

BCR::ABL1Flow cytometryFluorescence in situ hybridizationMixed-phenotype acute leukemia

Substanzen

Fusion Proteins, bcr-abl

Autor:innen und Institutionen

  • Department of Pathology, Duke University School of Medicine, Durham, NC, USA.
  • Duke Cancer Institute, Durham, NC, USA.
  • Department of Pathology, Duke University School of Medicine, Durham, NC, USA. eric.carlsen@duke.edu.
  • Duke Cancer Institute, Durham, NC, USA. eric.carlsen@duke.edu.

Zitieren

APA

Sotolongo, G. L., Carrillo, L. F., Young, K. H., Neff, J. L., & Carlsen, E. D. (2025). Distinct B/myeloid and T-lymphoblast populations at separate anatomic sites in mixed-phenotype acute leukemia with BCR::ABL1 fusion. Journal of Hematopathology. https://doi.org/10.1007/s12308-025-00660-8

Vancouver

Sotolongo GL, Carrillo LF, Young KH, Neff JL, Carlsen ED. Distinct B/myeloid and T-lymphoblast populations at separate anatomic sites in mixed-phenotype acute leukemia with BCR::ABL1 fusion. Journal of Hematopathology. 2025. doi:10.1007/s12308-025-00660-8

BibTeX
@article{Sotolongo2025,
  author = {Sotolongo, Gina L and Carrillo, Luis F and Young, Ken H and Neff, Jadee L and Carlsen, Eric D},
  title = {Distinct B/myeloid and T-lymphoblast populations at separate anatomic sites in mixed-phenotype acute leukemia with BCR::ABL1 fusion},
  journal = {Journal of Hematopathology},
  year = {2025},
  doi = {10.1007/s12308-025-00660-8}
}
Kostenlos starten →